Clinical Trial

Gracell Biotechnologies Wins Overall Immunology Solution of the Year by BioTech Breakthrough Awards Program

Third annual BioTech Breakthrough Award recognizes excellence in life science and biotechnology solutions, services and companies GC012F, a FasTCAR-enabled autologous…

8 months ago

Government Agencies Emphasize the Importance of Decentralized Methodologies for Future of Clinical Research

Decentralized Trials & Research Alliance brings together Global Leaders for its Annual Meeting SAN DIEGO, Nov. 08, 2023 (GLOBE NEWSWIRE)…

8 months ago

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

Biomerica remains on track for inFoods® IBS national rollout during calendar 2024, and expects strong product revenue growth during national…

8 months ago

Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights

Phase 1b Study of NXP800 in Patients with Platinum Resistant, ARID1a-Mutated Ovarian Carcinoma is Ongoing Initiated the Phase 1a Dose…

8 months ago

Ocular Therapeutix™ to Present at Three Upcoming Investor Conferences

BEDFORD, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development,…

8 months ago

PepGen Reports Third Quarter 2023 Financial Results and Recent Corporate Developments

- Continuing to open CONNECT1-EDO51 trial sites in Canada - - Opening of FREEDOM-DM1 trial sites underway in the U.S. and…

8 months ago

vTv Therapeutics to Participate at the Stifel 2023 Healthcare Conference

HIGH POINT, N.C., Nov. 08, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused…

8 months ago

Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer

-- Dr. Gaggar is an experienced industry executive with substantial infectious disease expertise and proven record of successfully leading early-…

8 months ago

DEA’s Disregard: Unraveling the Delays in MMJ’s Medical Marijuana Research of Suffering Law Enforcement Patients

DEA'S MANDATE IS DRUG DIVERSION, SECURITY AND TO FACILITATE DRUG DEVELOPMENT?DEA DIRECTOR ANNE MILGRAM THINKS DIFFERENTLY. LAW ENFORCEMENT OFFICERS SUFFER.WASHINGTON,…

8 months ago

Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension

Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S.PALO…

8 months ago